Repros Therapeutics

Summary

History

Mission

Vision

References

Summary

Repros Therapeutics is a biopharmaceutical company that specializes in the development of small molecule drugs for the diagnosis, treatment, and prevention of serious conditions affecting the safety and health of men and women.

History

Repros Therapeutics was founded in 1991 by Dr. Robert W. Clark who had a vision to develop innovative therapies focusing on male and female urological health. Since its founding, the company has grown to become an industry leader in the research and development of treatments for male and female urological conditions.

Mission

Repros Therapeutics strives to develop innovative therapeutic solutions that improve the lives of people affected by urological conditions.

Vision

To be a leader in the development of therapeutic solutions that improve the health and wellbeing of people affected by urological conditions.

References

https://in.investing.com/equities/repros-therapeutics

https://www.crunchbase.com/organization/repros-therapeutics

www.allergan.com/

Leadership team

Joseph S. Podolski (Founder)

Products / Services

Biopharma, Biotechnology, Pharmaceutical

Number of Employees

50 - 100

Address

Houston, Texas, United States

Established

1987-01-01

Company Registration

SEC CIK number: 0001802768

Net Income

S_100M_500M

Revenue

500M - 1B

Traded as

NASDAQ:RPRX

Website

www.allergan.com/

Last Updated: 2026

Repros Therapeutics

Share

Contacts

Follow Us

Repros Therapeutics

Share

Contacts

Follow Us